Merrion Pharmaceuticals, Inc. is Issued a Key United States Patent

Published: Mar 02, 2010

DUBLIN, Ireland, March 2, 2010 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals plc (IEX:MERR), an international specialty pharmaceutical company, today announced the issuance of United States Patent No. 7,658,938, "Solid Oral Dosage Form Containing an Enhancer." This patent covers the Company's GIPETĀ® enhancer system used with the bisphosphonate class of drugs. A patent covering the GIPET technology including its use with bisphosphonates has been previously granted in Europe.

Back to news